IN2014DN09830A - - Google Patents

Download PDF

Info

Publication number
IN2014DN09830A
IN2014DN09830A IN9830DEN2014A IN2014DN09830A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A IN 9830DEN2014 A IN9830DEN2014 A IN 9830DEN2014A IN 2014DN09830 A IN2014DN09830 A IN 2014DN09830A
Authority
IN
India
Prior art keywords
formula
vivo
exhibits
correction
enabling
Prior art date
Application number
Other languages
English (en)
Inventor
Chenfeng Ke
Anthony P Davis
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of IN2014DN09830A publication Critical patent/IN2014DN09830A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN9830DEN2014 2012-04-27 2013-04-26 IN2014DN09830A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1207392.0A GB201207392D0 (en) 2012-04-27 2012-04-27 Novel compounds
PCT/GB2013/051079 WO2013160701A1 (en) 2012-04-27 2013-04-26 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide

Publications (1)

Publication Number Publication Date
IN2014DN09830A true IN2014DN09830A (de) 2015-08-07

Family

ID=46330449

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9830DEN2014 IN2014DN09830A (de) 2012-04-27 2013-04-26

Country Status (9)

Country Link
US (2) US9610365B2 (de)
EP (1) EP2855439B1 (de)
CN (1) CN104428290B (de)
AU (1) AU2013254450A1 (de)
CA (1) CA2910581A1 (de)
GB (2) GB201207392D0 (de)
HK (1) HK1209112A1 (de)
IN (1) IN2014DN09830A (de)
WO (1) WO2013160701A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds
WO2018167503A1 (en) * 2017-03-15 2018-09-20 Ziylo Limited Macrocyclic compounds
WO2020058322A1 (en) * 2018-09-19 2020-03-26 Ziylo Ltd. Glucose sensitive insulins and uses thereof
PL4003165T3 (pl) * 2019-07-30 2024-06-10 Emd Millipore Corporation Sposób syntezy związków chemicznych
RU2752711C2 (ru) * 2019-11-18 2021-07-30 Общество с ограниченной ответственностью «Лаборатория межклеточных технологий «Интерсел Рэнд» (ООО «Интерсел Рэнд») Способ и устройство для спектроскопии живой ткани
KR20230127067A (ko) * 2022-02-24 2023-08-31 삼성에스디아이 주식회사 코어-쉘 염료, 이를 포함하는 근적외선 흡수성 수지 조성물 및 근적외선 흡수 필름

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6815901A (en) * 2000-06-02 2001-12-17 Zycos Inc Delivery systems for bioactive agents
JP2003073399A (ja) * 2001-08-31 2003-03-12 Japan Science & Technology Corp 発蛍光性修飾タンパク質
US7179616B1 (en) 2002-10-07 2007-02-20 University Of Notre Dame Du Lac Method for detecting phosphatidylserine on the surface of cells
US8642014B2 (en) * 2007-01-30 2014-02-04 Seta Biomedicals, Llc Luminescent compounds
WO2011059457A1 (en) * 2009-11-16 2011-05-19 University Of Notre Dame Du Lac High performance luminescent compounds
WO2011087521A1 (en) * 2010-01-13 2011-07-21 University Of Notre Dame Du Lac Chemiluminescent dyes and dye-stained particles
GB201207392D0 (en) 2012-04-27 2012-06-13 Univ Bristol Novel compounds

Also Published As

Publication number Publication date
GB2517345A (en) 2015-02-18
CN104428290B (zh) 2017-11-14
US20150147275A1 (en) 2015-05-28
US9610365B2 (en) 2017-04-04
AU2013254450A1 (en) 2014-11-27
US9937272B2 (en) 2018-04-10
GB201420937D0 (en) 2015-01-07
GB201207392D0 (en) 2012-06-13
WO2013160701A1 (en) 2013-10-31
HK1209112A1 (en) 2016-03-24
CN104428290A (zh) 2015-03-18
EP2855439B1 (de) 2017-06-14
US20170266321A1 (en) 2017-09-21
CA2910581A1 (en) 2013-10-31
EP2855439A1 (de) 2015-04-08

Similar Documents

Publication Publication Date Title
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
WO2014089209A3 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
EA201591064A1 (ru) Новые производные пиридина
WO2014062720A3 (en) Methods of treating cancer
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EA201591527A1 (ru) Новые производные пиридина
PH12012501905A1 (en) Quinoline derivatives and their use as fungicides
HK1199100A1 (en) Methods and compositions for the treatment and diagnosis of colorectal cancer
WO2013089882A3 (en) Recurrent gene fusions in breast cancer
WO2012158780A3 (en) Lung cancer signature
WO2015077635A8 (en) Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same
WO2014086982A3 (en) Stable metal compounds, their compositions and methods of their use
IN2014DN09830A (de)
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
MX388850B (es) Derivados de heteroarilpiperidina y de heteroarilpiperazina como fungicidas.
TR201909923T4 (tr) Böbrek hastalığının önlenmesi ya da tedavisi için pirazol türevini ihtiva eden kompozisyon.
WO2013103301A3 (en) Method for preparing cell targeting conjugates, and the complexes obtained
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
MX342947B (es) Tratamiento de diabetes tipo 2.
WO2014039533A3 (en) Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.